Myomo, Inc. (MYO) shareholders
Close on Nov 18, 2026Market cap $34.85MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rosalind Master Fund L.P. Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 7,554,046 | 9.90% | 13G (passive) amendment | Sep 30, 2025 |
| Rosalind Advisors, Inc. Joint filing with Salamon Steven A J (9.90%), Aharon Gil (9.90%) and 1 more | 7,401,144 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| Salamon Steven A J Joint filing with Rosalind Advisors, Inc. (9.90%), Aharon Gil (9.90%) and 1 more | 7,359,046 | 9.90% | 13G (passive) amendment | Jun 30, 2025 |
| Aharon Gil Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 7,279,046 | 9.90% | 13G (passive) amendment | Mar 31, 2025 |
| Norbert Gottesman Joint filing with Triple Gate Partners, LP (9.81%), Triple Gate Capital, LP (9.81%) and 1 more | 2,825,344 | 9.81% | 13G (passive) amendment | Dec 31, 2023 |
| Horton Capital Partners Fund, LP Joint filing with Horton Capital Partners, LLC (6.00%), Horton Capital Management, LLC (6.00%) and 1 more | 2,309,775 | 6.00% | 13D (active) amendment | May 9, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MYO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3,637,886 | 9.18% | $3.78M | −209,386 | 1.41% |
| Vanguard Capital Management LLC | 1,636,570 | 4.13% | $1.70M | +492,246 | 0.00% |
| Aqr Capital Management LLC | 928,268 | 2.34% | $965.40K | +609,317 | 0.00% |
| Jefferies Financial Group Inc. | 704,275 | 1.78% | $732.45K | – | 0.00% |
| Jane Street Group, LLC | 596,352 | 1.51% | $620.21K | New | 0.00% |
| Clearstead Advisors, LLC | 425,609 | 1.07% | $442.64K | +9 | 0.00% |
| UBS Group AG | 413,679 | 1.04% | $430.23K | +101,958 | 0.00% |
| Geode Capital Management, LLC | 344,417 | 0.87% | $358.31K | −514,382 | 0.00% |
| LPL Financial LLC | 308,000 | 0.78% | $320.32K | +2,000 | 0.00% |
| Palumbo Wealth Management LLC | 299,776 | 0.76% | $311.77K | New | 0.07% |
| Gsa Capital Partners Llp | 271,876 | 0.69% | $283.00K | +50,400 | 0.02% |
| Millennium Management LLC | 271,294 | 0.68% | $282.15K | New | 0.00% |
| BlackRock, Inc. | 223,217 | 0.56% | $232.15K | −1,465,173 | 0.00% |
| Vanguard Fiduciary Trust Co | 207,677 | 0.52% | $215.98K | −29,575 | 0.00% |
| Bnp Paribas Arbitrage, Snc | 139,194 | 0.35% | $144.76K | +131,048 | 0.00% |
| Ieq Capital, LLC | 127,749 | 0.32% | $132.86K | +93,910 | 0.00% |
| Susquehanna International Group, Llp | 120,791 | 0.30% | $125.62K | +82,402 | 0.00% |
| XTX Topco Ltd | 110,028 | 0.28% | $114.43K | +6,933 | 0.00% |
| State Street Corp | 105,875 | 0.27% | $110.11K | −277,316 | 0.00% |
| Citadel Advisors LLC | 102,518 | 0.26% | $106.62K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 80 | 12M | 30.8% | 24 / 27 | 20 / 22 | 3M | 4M |
| Q1 2026 | 80 | 13M | 32.3% | 16 / 21 | 23 / 11 | 2M | 2M |
| Q4 2025 | 76 | 14M | 35.8% | 19 / 28 | 12 / 9 | 3M | 2M |
| Q3 2025 | 66 | 14M | 34.5% | 13 / 20 | 20 / 29 | 2M | 8M |
| Q2 2025 | 82 | 19M | 48.5% | 28 / 30 | 15 / 22 | 7M | 3M |
| Q1 2025 | 76 | 16M | 40.3% | 14 / 36 | 17 / 8 | 3M | 2M |
| Q4 2024 | 71 | 15M | 37.1% | 34 / 15 | 12 / 4 | 5M | 0M |
| Q3 2024 | 41 | 10M | 24.8% | 12 / 13 | 7 / 3 | 2M | 0M |
| Q2 2024 | 34 | 12M | 29.2% | 5 / 13 | 6 / 5 | 2M | 0M |
| Q1 2024 | 34 | 10M | 25.1% | 7 / 14 | 7 / 10 | 2M | 2M |
| Q4 2023 | 37 | 9M | 23.9% | 17 / 12 | 4 / 4 | 4M | 1M |
| Q3 2023 | 24 | 6M | 15.5% | 10 / 6 | 3 / 1 | 3M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
56 funds held MYO in Q1 2026, 68% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MYO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,242,244 | 3.14% | $1.29M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 372,587 | 0.94% | $387.49K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 219,059 | 0.55% | $238.77K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 180,461 | 0.46% | $196.70K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 47,667 | 0.12% | $51.96K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 45,583 | 0.12% | $49.69K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 31,752 | 0.08% | $34.61K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 21,739 | 0.05% | $22.61K | 0.00% | Jun 30, 2026 |
| Small Cap Index Fund | 13,237 | 0.03% | $14.43K | 0.00% | May 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 10,229 | 0.03% | $10.64K | 0.00% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Growth Fund | 6,508 | 0.02% | $6.77K | 0.00% | Jun 30, 2026 |
| ProShares Russell 2000 High Income ETF | 1,694 | 0.00% | $1.85K | 0.00% | May 31, 2026 |
| ProShares UltraPro Russell2000 | 1,334 | 0.00% | $1.45K | 0.00% | May 31, 2026 |
| ProShares Ultra Russell2000 | 1,324 | 0.00% | $1.44K | 0.00% | May 31, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 203 | 0.00% | $211 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul R. Gudonis | Chief Executive Officer, Director | 1,514,292 | 3.82% | Oct 15, 2026 |
| David A. Henry | Chief Financial Officer | 549,862 | 1.39% | Oct 15, 2026 |
| Harry Kovelman | Chief Medical Officer | 89,889 | 0.23% | Oct 15, 2026 |
| Mary-Katherine Hale McClure | Chief Commericial Officer | 275,000 | 0.69% | Oct 13, 2026 |
| Micah Mitchell | Chief Commercial Officer | 152,297 | 0.38% | Aug 11, 2026 |
| Milton Mayo Morris | Director | 208,391 | 0.53% | Sep 4, 2026 |
| Joseph M. Manko Jr. | Director | 2,388,479 | 6.03% | Jun 26, 2026 |
| William J. Febbo | Director | 123,704 | 0.31% | Jun 26, 2026 |
| Thomas F. Kirk | Director | 772,569 | 1.95% | Jun 26, 2026 |
| Thomas Aloysius Crowley Jr. | Director | 154,931 | 0.39% | Jun 26, 2026 |
| Heather C. Getz | Director | 210,458 | 0.53% | Jun 26, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Harry Kovelman Chief Medical Officer | Oct 13, 2026 | Award | +32,500 | – | – | 122,389 |
| David A. Henry Chief Financial Officer | Oct 13, 2026 | Award | +51,250 | – | – | 549,862 |
| Paul R. Gudonis Chief Executive Officer, Director | Oct 13, 2026 | Award | +71,250 | – | – | 1,514,292 |
| David A. Henry Chief Financial Officer | Oct 12, 2026 | Tax withholding | −3,133 | $1.37 | $4.29K | 498,612 |
| Mary-Katherine Hale McClure Chief Commericial Officer | Oct 12, 2026 | Award | +275,000 | – | – | 275,000 |
| David A. Henry Chief Financial Officer | Oct 9, 2026 | Award | +6,272 | – | – | 501,745 |
| Paul R. Gudonis Chief Executive Officer, Director | Oct 9, 2026 | Award | +8,363 | – | – | 1,443,042 |
| Harry Kovelman Chief Medical Officer | Sep 11, 2026 | Sale | −15,844 | $1.27 | $20.14K | 89,889 |
| Harry Kovelman Chief Medical Officer | Sep 11, 2026 | Sale | −15,488 | $1.27 | $19.67K | 90,245 |
| Milton Mayo Morris Director | Sep 2, 2026 | Sale | −15,000 | $1.41 | $21.15K | 208,391 |
| Harry Kovelman Chief Medical Officer | Aug 20, 2026 | Sale | −17,500 | $1.73 | $30.28K | 105,733 |
| Harry Kovelman Chief Medical Officer | Aug 20, 2026 | Sale | −17,250 | $1.73 | $29.84K | 105,983 |
| Micah Mitchell Chief Commercial Officer | Aug 7, 2026 | Award | +58,409 | – | – | 152,297 |
| Micah Mitchell Chief Commercial Officer | Aug 7, 2026 | Tax withholding | −21,559 | $1.42 | $30.61K | 130,738 |
| David A. Henry Chief Financial Officer | Aug 7, 2026 | Tax withholding | −25,310 | $1.42 | $35.94K | 470,163 |
| David A. Henry Chief Financial Officer | Aug 7, 2026 | Award | +68,644 | – | – | 495,473 |
| Paul R. Gudonis Chief Executive Officer, Director | Aug 7, 2026 | Award | +146,909 | – | – | 1,434,679 |
| Harry Kovelman Chief Medical Officer | Aug 7, 2026 | Award | +55,149 | – | – | 145,690 |
| Harry Kovelman Chief Medical Officer | Aug 7, 2026 | Tax withholding | −22,457 | $1.42 | $31.89K | 123,233 |
| David A. Henry Chief Financial Officer | Jul 13, 2026 | Tax withholding | −5,166 | $1.09 | $5.63K | 426,829 |
| David A. Henry Chief Financial Officer | Jul 10, 2026 | Award | +7,840 | – | – | 431,995 |
| Paul R. Gudonis Chief Executive Officer, Director | Jul 10, 2026 | Award | +10,454 | – | – | 1,287,770 |
| Thomas F. Kirk Director | Jun 25, 2026 | Award | +78,704 | – | – | 772,569 |
| Milton Mayo Morris Director | Jun 25, 2026 | Award | +78,704 | – | – | 223,391 |
| William J. Febbo Director | Jun 25, 2026 | Award | +78,704 | – | – | 123,704 |
| Joseph M. Manko Jr. Director | Jun 25, 2026 | Award | +78,704 | – | – | 78,704 |
| Thomas Aloysius Crowley Jr. Director | Jun 25, 2026 | Award | +78,704 | – | – | 154,452 |
| Heather C. Getz Director | Jun 25, 2026 | Award | +78,704 | – | – | 210,458 |
| David A. Henry Chief Financial Officer | Jun 12, 2026 | Tax withholding | −10,969 | – | – | 424,155 |
| Micah Mitchell Chief Commercial Officer | Jun 12, 2026 | Tax withholding | −9,061 | $1.20 | $10.87K | 93,888 |
| Harry Kovelman Chief Medical Officer | Jun 12, 2026 | Tax withholding | −10,442 | $1.20 | $12.53K | 90,541 |
| Harry Kovelman Chief Medical Officer | Jun 8, 2026 | Tax withholding | −7,635 | $1.33 | $10.15K | 100,983 |
| David A. Henry Chief Financial Officer | Jun 8, 2026 | Tax withholding | −10,050 | – | – | 435,124 |
| Micah Mitchell Chief Commercial Officer | Jun 8, 2026 | Tax withholding | −6,529 | $1.33 | $8.68K | 102,949 |
| Thomas F. Kirk Director | Jun 5, 2026 | Buy | +40,002 | $1.27 | $50.80K | 693,865 |
| Thomas F. Kirk Director | May 28, 2026 | Buy | +25,000 | $0.99 | $24.75K | 653,863 |
| Harry Kovelman Chief Medical Officer | May 28, 2026 | Sale | −11,536 | $1.02 | $11.77K | 108,618 |
| Harry Kovelman Chief Medical Officer | May 27, 2026 | Sale | −20,464 | $1.00 | $20.46K | 120,154 |
| Thomas F. Kirk Director | May 18, 2026 | Buy | +43,401 | $0.91 | $39.49K | 628,863 |
| Joseph M. Manko Jr. Director | May 15, 2026 | Buy | +30,367 | $0.89 | $27.03K | 2,309,775 |
| Thomas F. Kirk Director | May 15, 2026 | Buy | +31,605 | $0.91 | $28.76K | 585,462 |
| Micah Mitchell Chief Commercial Officer | May 14, 2026 | Sale | −90,231 | $0.86 | $77.60K | 109,478 |
| Joseph M. Manko Jr. Director | May 14, 2026 | Buy | +170,830 | $0.86 | $146.91K | 2,279,408 |
| William J. Febbo Director | Apr 14, 2026 | Award | +45,000 | – | – | 45,000 |
| David A. Henry Chief Financial Officer | Apr 13, 2026 | Tax withholding | −3,953 | $0.71 | $2.81K | 445,174 |
| Paul R. Gudonis Chief Executive Officer, Director | Apr 10, 2026 | Award | +19,395 | – | – | 1,280,045 |
| Paul R. Gudonis Chief Executive Officer, Director | Apr 10, 2026 | Award | +16,666 | – | – | 1,277,316 |
| David A. Henry Chief Financial Officer | Apr 10, 2026 | Award | +12,500 | – | – | 449,127 |
| Heather C. Getz Director | Mar 16, 2026 | Buy | +20,000 | $0.70 | $14.00K | 131,754 |
| Thomas F. Kirk Director | Mar 13, 2026 | Buy | +72,000 | $0.71 | $51.12K | 553,857 |
| Heather C. Getz Director | Mar 12, 2026 | Buy | +70,000 | $0.73 | $51.10K | 111,754 |
| David A. Henry Chief Financial Officer | Jan 12, 2026 | Award | +8,727 | – | – | 436,627 |
| Paul R. Gudonis Chief Executive Officer, Director | Jan 12, 2026 | Award | +11,637 | – | – | 1,260,650 |
| Thomas F. Kirk Director | Nov 21, 2025 | Buy | +2,535 | $0.72 | $1.83K | 481,857 |
| Thomas F. Kirk Director | Nov 20, 2025 | Buy | +4,902 | $0.72 | $3.53K | 479,322 |
| Thomas Aloysius Crowley Jr. Director | Nov 19, 2025 | Buy | +385 | $0.77 | $296 | 479 |
| Thomas Aloysius Crowley Jr. Director | Nov 18, 2025 | Buy | +4,000 | $0.73 | $2.92K | 75,748 |
| Paul R. Gudonis Chief Executive Officer, Director | Sep 9, 2025 | Gift | −10,000 | – | – | 1,249,013 |
| Thomas F. Kirk Director | Aug 25, 2025 | Buy | +50,000 | $1.15 | $57.50K | 474,420 |
| Thomas F. Kirk Director | Aug 18, 2025 | Buy | +50,000 | $1.10 | $55.00K | 424,420 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Myomo's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,903 shares on Sep 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| David A. Henry Officer | Oct 13, 2026 | 3,133 | $4.29K | Oct 12, 2026 | Vesting of Restricted Stock Units |
| Harry Kovelman Officer | Sep 11, 2026 | 15,844 | $20.14K | Sep 11, 2026 | Restricted Stock |
| Milton Mayo Morris Director | Sep 2, 2026 | 15,000 | $21.15K | Sep 2, 2026 | RSU VEST |
| Harry Kovelman Officer | Aug 20, 2026 | 17,500 | $30.33K | Aug 20, 2026 | Restricted Stock |
| David A. Henry Officer | Jul 13, 2026 | 5,166 | $5.63K | Jul 13, 2026 | Vesting of Restricted Stock Units |
| Micah Mitchell Officer | Jun 12, 2026 | 9,061 | $10.87K | Jun 12, 2026 | Vesting of Restricted Stock Units |
| Harry Kovelman Officer | Jun 12, 2026 | 10,442 | $12.53K | Jun 12, 2026 | Vesting of Restricted Stock Units |
| Micah Mitchell Officer | Jun 8, 2026 | 6,529 | $8.68K | Jun 8, 2026 | Vesting of Restricted Stock Units |
| Harry Kovelman Officer | Jun 8, 2026 | 7,635 | $10.15K | Jun 8, 2026 | Vesting of Restricted Stock Units |
| Harry Kovelman Officer | May 28, 2026 | 11,536 | $11.73K | May 28, 2026 | Restricted Stock |
| Harry Kovelman Officer | May 27, 2026 | 20,464 | $20.47K | May 27, 2026 | Restricted Stock |
| Micah Mitchell Officer | May 14, 2026 | 90,231 | $77.69K | May 14, 2026 | Restricted Stock |
| David A. Henry Officer | Apr 13, 2026 | 3,953 | $2.81K | Apr 13, 2026 | Vesting of Restricted Stock Units |
| Harry Kovelman Officer | Jun 30, 2025 | 13,054 | $28.59K | Jun 28, 2025 | Vesting of Restricted Stock Units |
| David A. Henry Officer | Jun 30, 2025 | 23,587 | $51.66K | Jun 30, 2025 | Vesting of Restricted Stock Units |
See a number that looks wrong?